BackBlackRock Health Sciences Opportunities Portfolio Overview

BlackRock Health Sciences Opportunities Portfolio Profit Margin

BlackRock Health Sciences Opportunities Portfolio (SHSCX) has a profit margin of 1.68%, below the sector sector average of 13.2%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-0.34%
↓ 113.20% YoY

As of Mar 2025

Annual Profit Margin (TTM)

1.68%

Trailing 12 months ending Mar 2025

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

BlackRock Health Sciences Opportunities Portfolio (SHSCX) FAQ

BlackRock Health Sciences Opportunities Portfolio (SHSCX) currently reports a profit margin of 1.68% as of March 2025. That is below the sector sector average of 13.2%. Use the charts on this page to explore BlackRock Health Sciences Opportunities Portfolio's profit margin history and peer comparisons.

BlackRock Health Sciences Opportunities Portfolio's profit margin of 1.68% is lower than the its sector sector average of 13.2%. That is roughly 87.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but BlackRock Health Sciences Opportunities Portfolio's current 1.68% should be judged against industry norms (sector average: 13.2%) and against SHSCX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 1.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for BlackRock Health Sciences Opportunities Portfolio, and consider following SHSCX for alerts when major investors trade the stock.